TheLaosTime

WAT Medical’s EmeTerm Wearable Device Demonstrates Superior Control of Moderate to Severe Postoperative Nausea and Vomiting in JAMA Surgery-Published Clinical Trial

2026-02-09 - 19:38

VANCOUVER, BC, Feb. 10, 2026 /PRNewswire/ — WAT Medical is proud to announce the publication of a landmark randomized clinical trial in JAMA Surgery, one of the world’s most reputable and high-impact surgical journals. The study confirms that the EmeTerm wristband — a wearable device utilizing transcutaneous acupoint electrical stimulation — provides significantly better control

Share this post: